CAS: 1446790-62-0
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
RO9021 REF: AN-AG00ABT7CAS: 1446790-62-0 | 99% | 160.00 €~4,157.00 € | Wed 08 May 24 | |
RO9021 REF: TM-T16776CAS: 1446790-62-0 | 98% | 85.00 €~2,211.00 € | Wed 15 May 24 | |
RO9021 REF: 3D-WHC79062CAS: 1446790-62-0 | Min. 95% | To inquire | Thu 20 Jun 24 |
Ref: AN-AG00ABT7
1mg | 160.00 € | |
5mg | 597.00 € | |
10mg | 648.00 € | |
25mg | 1,048.00 € | |
50mg | 1,429.00 € | |
100mg | 2,079.00 € | |
500mg | 4,157.00 € |
Estimated delivery in United States, on Wednesday 8 May 2024
RO9021
CAS:1446790-62-0
RO9021 is an orally bioavailable, novel ATP-competitive SYK inhibitor (average IC50: 5.6 nM).
Formula:
C18H25N7O
Purity:
98%
Color and Shape:
Solid
Molecular weight:
355.44
Ref: TM-T16776
1mg | 85.00 € | |
5mg | 222.00 € | |
10mg | 337.00 € | |
25mg | 573.00 € | |
50mg | 811.00 € | |
100mg | 1,096.00 € | |
500mg | 2,211.00 € |
Estimated delivery in United States, on Wednesday 15 May 2024
RO9021
CAS:1446790-62-0
RO9021 is a novel, orally bioavailable, small-molecule CDK4/6 inhibitor that blocks the cell cycle at …
Formula:
C18H25N7O
Purity:
Min. 95%
Molecular weight:
355.44 g/mol
Ref: 3D-WHC79062
1mg | To inquire | |
5mg | To inquire | |
10mg | To inquire | |
25mg | To inquire | |
50mg | To inquire |
Estimated delivery in United States, on Thursday 20 Jun 2024